To assess the safety, tolerability, pharmacokinetics and pharmacodynamics of multiple doses AZD8848 in healthy subjects

Study identifier:D0542C00002

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A Phase 1, Single Centre, Double-blind, Randomised, Placebo-controlled, Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics after Administration of Multiple Ascending (MAD) Once Weekly Inhaled Doses of AZD8848 in Healthy Subjects

Medical condition

Safety,, Healthy subjects

Phase

Phase 1

Healthy volunteers

Yes

Study drug

AZD8848, Placebo to match AZD8848

Sex

All

Actual Enrollment

8

Study type

Interventional

Age

18 Years - 50 Years

Date

Study Start Date: 01 Jan 2014
Primary Completion Date: 01 Feb 2014
Study Completion Date: 01 Feb 2014

Study design

Allocation: Randomized
Endpoint Classification: Safety Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Basic Science

Verification:

Verified 01 Aug 2015 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria